I've read a lot of posts from angry EXAS shareholders lately and to be quite frank, I think they are a bit confused. In their greed inspired inability to think "outside the box", these poor dolts dont understand the value of synergy. Sure you could just go out and buy some Sequenom and sit on your existing shares until the next offer comes in at 3.00 (and gets accepted). Or you could open your mind and truly prosper! The proposition you have before you goes like this:
1)The company doesnt sell to Sequenom but instead get's bought out by another firm; 1+1=2
OR) The company allows SQNM to take over and exploit their patents within their existing market and in conjunction with their other products. Net result? 1+1=10!
The combined value of is far greater than the sum of the two, as it allows EACH company to maximize it's potential. SQNM could easily be a 10 bagger, as has been said many times over; the GOOGLE of Genomic Science.
Think about it wont you? Before you shoot yourselves in the foot!
Far from being the "Google of Genomic Sciences," Sequenom is currently disgraced and discredited. Just think--EXAS could have accepted $1.50 a share from SQNM paid in a stock that has since declined in value by about 70%. What a great deal that would have been--a current value of $0.45 per share. And of course SQNM is doing SO well, missing earnings estimates for four straight quarters and delaying the launch of their lead product by a full year. Who needs that kind of management?
Really? Do you really believe this now you tard? Now that sqnm is down 80%!? EIGHTY PERCENT!!! think about that! and you still bark, how sad for you SQNM losers, it's really sad. Oh well, should have listened to Pro I guess then you wouldn't be broke! LOL
Given that Suckonem is over valued by about 50%, and the dollar offer to EXAS is no better than half what it should be- and probably less than a third, let's du some math.
Suckonem is should probably be traded around a $500m market cap. EXAS should be near the middle of it's highs and lows of the past couple years, or about $100m market cap. In a combined company, the earnings would probably be about equally du both companies. So, for Suckonem to buy Exact, they would need to offer about a 1:5 share deal valuing EXAS north of $200m based on current share prices, but really not.
You wish doper, SQNM trades at LESS THAN 1 times the 2009 earnings projections. You and the hedge fund manager (who wrote the article you refer to) must have gotten your proverbials caught in the vice and now you're making up crap and telling lies in the hope of stemming your painful losses.
Bash SQNM all you want, but it still isnt going to raise the value of this hopeless shell corporation! It's already seen a 100% rise in valuation thanks to Sequenom! One would think you greedy SOB's might be a little more greatful!
.....Good luck chump.
It will. The unstable narket is the only thing holding it down from big jumps. I see it being bought by a big boy BEFORE it soars. Either way, it is NO LONGER a small cap stock. All you need is a viable P/E and it's done